Corrigendum to "Genetic Mutations of Tim-3 Ligand and Exhausted Tim-3+ CD8+ T Cells and Survival in Diffuse Large B Cell Lymphoma"

Corrigendum to "Genetic Mutations of Tim-3 Ligand and Exhausted Tim-3⁺ CD8⁺ T Cells and Survival in Diffuse Large B Cell Lymphoma"

J Immunol Res. 2021 Jan 30:2021:4972043. doi: 10.1155/2021/4972043. eCollection 2021.

¹ Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, The Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China.
² Panovue Biological Technology Co., Ltd., Beijing, China.
³ Marvel Medical Laboratory, Tianjin Marvelbio Technology Co. Ltd., Tianjin, China.
⁴ Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
⁵ Department of Immunology/Biotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.

[This corrects the article DOI: 10.1155/2020/6968595.].